Improvement in 3 noninvasive tests through 144 weeks of bulevirtide monotherapy in patients with chronic hepatitis Delta with and without virologic response

M Brunetto, S Aleman, P Andreone, P Bogomolov, V Chulanov, N Geyvandova, V Morozov, O Sagalova, T Stepanova, K Deterding, A Lichtman, R-C Mercier, D Manuilov, M Li, J Schulze zur Wiesch, S Zeuzem, H Wedemeyer, P Lampertico · Zeitschrift für Gastroenterologie · 2025 · Heft 08 · S. e555-e556